ZC0

Contezolid

Created:	2020-04-29
Last modified:	2020-06-05

Find Related PDB Entry
1 entries where ZC0 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	44
Chiral Atom Count	1
Bond Count	47
Aromatic Bond Count	11

2D diagram of ZC0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Contezolid
Synonyms	MRX-I
Systematic Name (OpenEye OEToolkits)	(5~{S})-5-[(1,2-oxazol-3-ylamino)methyl]-3-[2,3,5-tris(fluoranyl)-4-(4-oxidanylidene-2,3-dihydropyridin-1-yl)phenyl]-1,3-oxazolidin-2-one
Formula	C₁₈ H₁₅ F₃ N₄ O₄
Molecular Weight	408.331
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1C(C=CN(C1)c2c(F)cc(c(c2F)F)N3CC(OC3=O)CNc4ccon4)=O
SMILES	CACTVS	3.385	Fc1cc(N2C[CH](CNc3ccon3)OC2=O)c(F)c(F)c1N4CCC(=O)C=C4
SMILES	OpenEye OEToolkits	2.0.7	c1conc1NCC2CN(C(=O)O2)c3cc(c(c(c3F)F)N4CCC(=O)C=C4)F
Canonical SMILES	CACTVS	3.385	Fc1cc(N2C[C@H](CNc3ccon3)OC2=O)c(F)c(F)c1N4CCC(=O)C=C4
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1conc1NC[C@H]2CN(C(=O)O2)c3cc(c(c(c3F)F)N4CCC(=O)C=C4)F
InChI	InChI	1.03	InChI=1S/C18H15F3N4O4/c19-12-7-13(15(20)16(21)17(12)24-4-1-10(26)2-5-24)25-9-11(29-18(25)27)8-22-14-3-6-28-23-14/h1,3-4,6-7,11H,2,5,8-9H2,(H,22,23)/t11-/m0/s1
InChIKey	InChI	1.03	SULYVXZZUMRQAX-NSHDSACASA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB12796
Name	MRX-I
Groups	investigational
Description	MRX-I has been used in trials studying the treatment of Bacterial Infections.
Synonyms	MRX-I
CAS number	1112968-42-9

Related Resource References

Resource Name	Reference
PubChem	25184541
ChEMBL	CHEMBL3287379

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.